Volitionrx limited reports earnings results for the third quarter ended september 30, 2019

Volitionrx limited announced earnings results for the third quarter ended september 30, 2019. for the third quarter, the company announced total revenue was usd 17,096 compared to usd 0 a year ago. operating loss was usd 4.176 million compared to usd 4.447 million a year ago. net loss was usd 4.180 million compared to usd 4.476 million a year ago. basic loss per share from continuing operations was usd 0.1 compared to usd 0.14 a year ago. for the nine months, total revenue was usd 17,096 compared to usd 0 a year ago. operating loss was usd 12.317 million compared to usd 13.642 million a year ago. net loss was usd 12.541 million compared to usd 13.721 million a year ago. basic loss per share from continuing operations was usd 0.33 compared to usd 0.46 a year ago.
VNRX Ratings Summary
VNRX Quant Ranking